FDA Approves First Treatment for Hunter Syndrome

Families affected by Hunter syndrome now have hope as the FDA approves Avlayah, the first treatment designed to replace a missing enzyme that causes dangerous sugar buildup in the brain.

This breakthrough marks a major victory for patients with this rare genetic disease.